Zylox-Tonbridge and GL Capital to acquire 16.73% stake in LifeTech Scientific for $189M

Zylox-Tonbridge Medical Technology and GL Capital conditionally agreed to subscribe for approximately 16.73% of LifeTech Scientific Corporation for HK$1.482 billion ($189 million), with intent to pursue a full merger to create China's largest listed cardiovascular interventional device company.

“both buyers have made explicit in the transaction announcement their intent to pursue a full merger — a step that would create China's most broadly diversified listed cardiovascular interventional device company.”techtimes.com

• 1 source
• techtimes.comChina's Medtech Merger Wave: Zylox-Tonbridge Puts $189M on LifeTech Scientific to Build a Cardiovascular Device PlatformBenjamin EddieNov 7, 2026

Summarized from public sources; check the original articles before acting on it.